Similarly, IL1 was shown to be produced by tumor infiltrating myeloid cells in the tumor microenvironment and neutralizing IL1 receptor inhibits breast cancer progression in vivo in a humanized mouse model(27), indicating the importance of paracrine IL-1β in tumor growth and progression. This evidence concerns the gene IL1B and breast cancer.